World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
45
Citations
11338
World Ranking
4962
National Ranking
1925

Peter Abbink publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Peter Abbink sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 87 publications — 2nd percentile

2% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Peter Abbink D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Peter Abbink sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 45 D-Index — 10th percentile

10% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Peter Abbink is affiliated with Harvard Medical School in the United States, focusing primarily on medical research. Their work spans several fields, with a strong emphasis on infectious diseases.

The main fields of study associated with their research include:

  • Medicine

Within medicine, their subfields of study are:

  • Infectious Diseases
  • Public Health, Environmental and Occupational Health
  • Epidemiology
  • Virology
  • Cardiology and Cardiovascular Medicine

Peter Abbink's research topics cover various areas, notably:

  • Mosquito-borne diseases and control
  • HIV Research and Treatment
  • Viral Infections and Vectors
  • Virology and Viral Diseases
  • HIV/AIDS drug development and treatment
  • HIV/AIDS Research and Interventions
  • Malaria Research and Control

Recent publications by Peter Abbink include:

  • "SARS-CoV-2 infection protects against rechallenge in rhesus macaques", 2020, Science
  • "Safety and antiviral activity of triple combination broadly neutralizing monoclonal antibody therapy against HIV-1: a phase 1 clinical trial", 2022, Nature Medicine
  • "Safety, pharmacokinetics and antiviral activity of PGT121, a broadly neutralizing monoclonal antibody against HIV-1: a randomized, placebo-controlled, phase 1 clinical trial", 2021, Nature Medicine
  • "Potent Zika and dengue cross-neutralizing antibodies induced by Zika vaccination in a dengue-experienced donor", 2020, Nature Medicine
  • "A Double-Blind, Randomized, Placebo-Controlled Phase 1 Study of Ad26.ZIKV.001, an Ad26-Vectored Anti-Zika Virus Vaccine", 2021, Annals of Internal Medicine

Frequent co-authors in their work comprise:

  • Dan H. Barouch
  • Joseph P. Nkolola
  • Erica N. Borducchi
  • Abishek Chandrashekar
  • Noe B. Mercado

The venues where Peter Abbink most frequently publishes include:

  • Nature Medicine
  • Nature Communications
  • Science
  • Annals of Internal Medicine
  • Nature Biomedical Engineering

Best Publications

  • SARS-CoV-2 infection protects against rechallenge in rhesus macaques.

    Abishek Chandrashekar;Jinyan Liu;Amanda J. Martinot;Amanda J. Martinot;Katherine McMahan

  • Comparative Seroprevalence and Immunogenicity of Six Rare Serotype Recombinant Adenovirus Vaccine Vectors from Subgroups B and D

    Peter Abbink;Angelique A. C. Lemckert;Bonnie A. Ewald;Diana M. Lynch

  • Hexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunity

    Diane M. Roberts;Anjali Nanda;Menzo J. E. Havenga;Peter Abbink

  • Vaccine protection against Zika virus from Brazil

    Rafael A. Larocca;Peter Abbink;Jean Pierre S. Peron;Paolo M. de A. Zanotto

  • Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys

    Peter Abbink;Rafael A. Larocca;Rafael A. De La Barrera;Christine A. Bricault

  • Immune Control of an SIV Challenge by a T Cell-Based Vaccine in Rhesus Monkeys

    Jinyan Liu;Kara L. O’Brien;Diana M. Lynch;Nathaniel L. Simmons

  • Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys

    Dan H. Barouch;Dan H. Barouch;Jinyan Liu;Hualin Li;Lori F. Maxfield

  • Mosaic HIV-1 vaccines expand the breadth and depth of cellular immune responses in rhesus monkeys

    Dan H. Barouch;Dan H. Barouch;Kara L. O'Brien;Nathaniel L. Simmons;Sharon L. King

  • Rapid development of a DNA vaccine for Zika virus

    Kimberly A. Dowd;Sung-Youl Ko;Kaitlyn M. Morabito;Eun Sung Yang

  • Protective Efficacy of a Global HIV-1 Mosaic Vaccine against Heterologous SHIV Challenges in Rhesus Monkeys

    Dan H. Barouch;Dan H. Barouch;Kathryn E. Stephenson;Erica N. Borducchi;Kaitlin Smith

  • International Seroepidemiology of Adenovirus Serotypes 5, 26, 35, and 48 in Pediatric and Adult Populations

    Dan H. Barouch;Dan H. Barouch;Sandra V. Kik;Gerrit J. Weverling;Rebecca Dilan

  • Antibody and TLR7 agonist delay viral rebound in SHIV-infected monkeys

    Erica N. Borducchi;Jinyan Liu;Joseph P. Nkolola;Anthony M. Cadena

  • Protective Efficacy of Adenovirus/Protein Vaccines Against SIV Challenges in Rhesus Monkeys

    Dan H. Barouch;Dan H. Barouch;Galit Alter;Thomas Broge;Caitlyn Linde

  • Pathogenic Simian Immunodeficiency Virus Infection Is Associated with Expansion of the Enteric Virome

    Scott A. Handley;Larissa B. Thackray;Guoyan Zhao;Rachel Presti

  • Ad26/MVA therapeutic vaccination with TLR7 stimulation in SIV-infected rhesus monkeys

    Erica N. Borducchi;Crystal Cabral;Kathryn E. Stephenson;Jinyan Liu

  • Preliminary aggregate safety and immunogenicity results from three trials of a purified inactivated Zika virus vaccine candidate: phase 1, randomised, double-blind, placebo-controlled clinical trials.

    Kayvon Modjarrad;Leyi Lin;Sarah L George;Sarah L George;Kathryn E Stephenson;Kathryn E Stephenson

  • Zika Virus Persistence in the Central Nervous System and Lymph Nodes of Rhesus Monkeys.

    Malika Aid;Peter Abbink;Rafael A. Larocca;Michael Boyd

  • First-in-Human Evaluation of the Safety and Immunogenicity of a Recombinant Adenovirus Serotype 26 HIV-1 Env Vaccine (IPCAVD 001)

    Lindsey R. Baden;Lindsey R. Baden;Lindsey R. Baden;Stephen R. Walsh;Stephen R. Walsh;Michael S. Seaman;Michael S. Seaman;Robert P. Tucker

  • Vaccine-Induced Protection from Homologous Tier 2 SHIV Challenge in Nonhuman Primates Depends on Serum-Neutralizing Antibody Titers.

    Matthias G. Pauthner;Joseph P. Nkolola;Colin Havenar-Daughton;Colin Havenar-Daughton;Ben Murrell

  • Magnitude and Phenotype of Cellular Immune Responses Elicited by Recombinant Adenovirus Vectors and Heterologous Prime-Boost Regimens in Rhesus Monkeys

    Jinyan Liu;Bonnie A. Ewald;Diana M. Lynch;Matthew Denholtz

Frequent Co-Authors

Dan H. Barouch
Dan H. Barouch Harvard Medical School
Michael S. Seaman
Michael S. Seaman Beth Israel Deaconess Medical Center
Mark G. Lewis
Mark G. Lewis Walter Reed Army Institute of Research
Nelson L. Michael
Nelson L. Michael Walter Reed Army Institute of Research
Lindsey R. Baden
Lindsey R. Baden Brigham and Women's Hospital
Michael R. Boyd
Michael R. Boyd National Cancer Institute
Jaap Goudsmit
Jaap Goudsmit Harvard University
Raphael Dolin
Raphael Dolin Beth Israel Deaconess Medical Center
Keith G. Mansfield
Keith G. Mansfield Novartis (Switzerland)

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology in the USA opens doors to diverse career paths, many of which intersect with healthcare and information management sectors. For those interested in medical coding, becoming a Certified Professional Coder (CPC) offers a promising career with competitive pay. Exploring the cpc salary and career paths can help you understand the benefits and requirements of this profession.

Alternatively, health information management is a growing field that blends healthcare knowledge with data management technologies. Learning about the health information manager salary and job outlook can guide students toward this rewarding career.

If you want to pursue formal education in this area, consider enrolling in a cahiim accredited him degree online. These programs provide essential skills for managing healthcare data effectively and are recognized by industry leaders.

For quicker entry into the healthcare documentation field, many opt for an accredited fast medical billing and coding certificate online. This offers an accelerated pathway to begin working in medical billing and coding, complementing a microbiology background with administrative expertise.

Best Scientists Citing Peter Abbink

Trending Scientists

Recently Published Articles